Impact of Atorvastatin on Prostate Cancer Progression During ADT

Clinical trial NCT04026230 · UNKNOWN

Trial details

NCT number: NCT04026230
Sponsor: Tampere University Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Recurrent Prostate Cancer

Start date: 2019-08-15
Primary completion: 2025-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.